Maxim Group started coverage on shares of KindlyMD (NASDAQ:NAKA – Free Report) in a report released on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $8.00 target price on the stock.
KindlyMD Price Performance
Shares of NAKA stock opened at $4.08 on Wednesday. KindlyMD has a 52 week low of $0.65 and a 52 week high of $34.77. The stock has a market cap of $1.53 billion, a PE ratio of -4.74 and a beta of 33.96. The firm has a 50 day simple moving average of $9.99.
KindlyMD (NASDAQ:NAKA – Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.34) EPS for the quarter. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%. The business had revenue of $0.41 million during the quarter.
About KindlyMD
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.
Featured Stories
- Five stocks we like better than KindlyMD
- Growth Stocks: What They Are, Examples and How to Invest
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- How to Invest in Insurance Companies: A Guide
- Lululemon Share Price Has Plenty of Room Left to Fall
- Investing in the High PE Growth Stocks
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
